Liquid chromatography-mass spectrometry system for metabolite-based precision medicine
Liquid chromatography-mass spectrometry system for metabolite-based precision medicine
批准号:
MR/X013758/1
负责人:
Warwick Dunn
金额:
$58.85万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2022
资助国家:
英国
项目状态:
已结题
起止时间:
2022 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Metabolites are small biochemicals present in every human cell, tissue and biofluid. These metabolites are essential for life, are primarily involved in metabolism and include sugars and fats which are important for the generation of energy through metabolism of food. Metabolites have other important roles which help us live including the construction of other biochemicals (proteins and DNA), construction of cell walls with fats and the control of chemical processes in the body in response to environmental changes including eating and exercise. The amounts of metabolites in our bodies change in response to environmental changes or in relation to the development and progression of diseases. As examples, the metabolite lactic acid quickly increases in amounts in muscle tissue and blood during exercise and the metabolite glucose increases in blood in the disease diabetes. In scientific research we study metabolites to understand how we age and how disease processes start and progress. This research can help us understand how diseases develop, help us identify new treatments for diseases and help us diagnose a disease or define the risk of developing a disease early which reduces the level and intensity of treatment and increases the probability of long term survival. The research to be performed will apply the study of thousands of metabolites and this scientific technique is called metabolomics. We will apply a scientific instrument called liquid chromatography-mass spectrometry to allow detection of metabolites based on their weight as different metabolites have different weights (masses). Metabolomics allows the study of thousands of metabolites in discovery research, identification of a small number of important metabolites related to the clinical question and translation in to clinical practice. Metabolites are already used for disease diagnosis including glucose for diagnosis of diabetes. Metabolomics will be applied to study a range of diseases including cancers (lung, blood colorectal), cardiovascular diseases, hormone-driven diseases and women's health/pregnancy disorders.Importantly, not all humans are the same in how diseases develop and response to different treatments. Traditional medicine treated everyone as if they were the same. A new era of precision medicine is upon us and is an innovative approach to tailoring disease prevention and treatment that takes into account differences in people's genes, environments, and lifestyles. The goal of precision medicine is to target the right treatments to the right patients at the right time. The studies performed will help develop new precision medicine tools for early disease diagnosis or for development of different treatments.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/s41596-022-00801-8
发表时间:
2023-02-24
期刊:
NATURE PROTOCOLS
影响因子:
14.8
作者:
[Sarmad,Sarir, Viant,Mark R., Suzuki,Toru]
通讯作者:
Suzuki,Toru
2020BBSRC-NSF/BIO: Linking Mass Spectrometry Computational Ecosystems to Enhance Biological Insights of Publicly-Available Data
-
批准号:BB/W002345/1
-
项目类别:Research Grant
-
资助金额:$81.42万
-
财政年份:2022
-
负责人:Warwick Dunn
-
依托单位:
Standardised metabolite annotation workflows for enhanced biological interpretation in metabolomic data repositories
-
批准号:BB/T007974/2
-
项目类别:Research Grant
-
资助金额:$38.51万
-
财政年份:2021
-
负责人:Warwick Dunn
-
依托单位:
Standardised metabolite annotation workflows for enhanced biological interpretation in metabolomic data repositories
-
批准号:BB/T007974/1
-
项目类别:Research Grant
-
资助金额:$72.89万
-
财政年份:2020
-
负责人:Warwick Dunn
-
依托单位:
Next generation tools for the annotation of metabolites in global LC-MS metabolomic studies
-
批准号:BB/N023013/1
-
项目类别:Research Grant
-
资助金额:$11.64万
-
财政年份:2016
-
负责人:Warwick Dunn
-
依托单位:
国内基金
海外基金
应用iTRAQ定量蛋白组学方法分析乳腺癌新辅助化疗后相关蛋白质的变化
-
批准号:81150011
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2011
-
负责人:李席如
-
依托单位: